13th Key Symposium 2016: Bioelectronic Medicine
Technology Targeting Molecular Mechanisms
Wednesday, September 21 – Friday, September 23


Bioelectronic medicine — the convergence of molecular medicine; neuroscience and biology; and electronics and computing to develop cures — may change the future of therapies for a wide variety of diseases. This groundbreaking discipline is aimed at interfacing electronics with nerves to specifically target the biological processes underlying disease. Bioelectronic medicine is now at the epicenter of where healthcare, technology, and science converge. A unique moment exists to characterize the challenges and opportunities facing the future of this scientific domain.

The Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms, will convene thought leaders who have the potential to explore, define, and create this new field. Session topics include: Defining Circuits, Cell Biology and Cancer, Molecular Sensing, Clinical Updates, Brain Interfaces, Processing the Future, and Funding the Field. By harnessing the power of technology spanning disciplines from microfluidics to computer processing to molecular technology, we step closer to the promise of bioelectronic medicine — to naturally reproduce a drug’s therapeutic reaction by mobilizing the body’s natural reflexes to develop effective, safe and economical alternatives to pills and injectables.

Presented By: The Feinstein Institute for Medical Research, the Journal of Internal Medicine, the Royal Swedish Academy of Sciences, and The New York Academy of Sciences.

For more information and to register, click here.

Please see the link above.
There are more than 15 international speakers including Kevin J. Tracey, MD, Chad Bouton, and Peder Olofsson, MD, PhD. For a list of all speakers, please refer to the link above.
7 World Trade Center
250 Greenwich Street
40th floor
New York, NY 10007-2157